Tirzepatide causes injection-site reactions and rare skin adverse events, but its immunomodulatory properties show potential for treating inflammatory skin diseases like psoriasis and hidradenitis suppurativa.
Dual skin impactTirzepatide causes skin adverse events but may also treat inflammatory skin diseases through immunomodulation
What the researchers found
Tirzepatide causes injection-site reactions comparable to semaglutide, rare severe dermatologic events, and facial volume loss from rapid weight loss, but shows immunomodulatory potential for inflammatory skin diseases.
Why it matters
As millions take tirzepatide, understanding its skin effects—both adverse and potentially therapeutic—helps dermatologists, prescribers, and patients make informed decisions.
How the study worked
Narrative review of SURPASS clinical trials, case reports, pharmacovigilance data (PubMed, Scopus, Google Scholar through May 2025) focusing on dermatologic effects.
What this study cannot tell us
Therapeutic skin benefits based on case reports only. Cosmetic effects are subjective. Pharmacovigilance data may underrepresent events.
How to read the evidence
Review of clinical trial safety data and case reports. Safety data well-established; therapeutic skin benefits are preliminary.
When this study was published
Published in 2025.
The bigger picture
The skin effects of GLP-1/GIP drugs are an emerging area as use expands. The dual therapeutic/adverse skin profile mirrors the broader pattern of GLP-1 drug pleiotropic effects.
Questions still open
- Should dermatologists actively investigate tirzepatide for psoriasis in clinical trials?
- Can cosmetic interventions (fillers) safely address tirzepatide-induced facial volume loss?
- Do skin adverse events differ between branded and compounded tirzepatide?
Common questions
Does tirzepatide cause skin problems?
Could tirzepatide treat skin conditions?
Read the original research
Tirzepatide in dermatology: cutaneous adverse events, emerging therapeutic roles, and cosmetic implications - A comprehensive review.
Anais brasileiros de dermatologia, 101(1), 501255
Citation
El-Amawy, Heba Saed. (2026). Tirzepatide in dermatology: cutaneous adverse events, emerging therapeutic roles, and cosmetic implications - A comprehensive review.. Anais brasileiros de dermatologia, 101(1), 501255. https://doi.org/10.1016/j.abd.2025.501255